Targeting CML CD34+ cells with BMP receptor inhibitors resulted in fewer cell divisions, reduced numbers of CD34+ cells and colony formation when compared to normal donor CD34+ cells, both in the presence and absence of BMP4. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.